🌐 Language / 語言 / 言語 / Idioma: English 中文 日本語 Español 📋 Korean Law Insight | Korean Legal System By Attorney NOH UJIN | HANBYOL LAW LLC, Seoul Public Notary (공증) System in Korea: A Complete Legal Guide to Document Authentication for Foreign Individuals and Businesses Korea's notarization system — operating under the Notary Public Act (공증인법) and the Civil Procedure Code's provisions on notarial deeds — differs significantly from common-law notary systems familiar to many foreign businesspeople and individuals. Understanding how Korean public notaries (공증인) function is essential for anyone executing powers of attorney, loan agreements, corporate resolutions, or other documents intended for use in Korea or abroad. 1. What Is a Korean Public Notary, and How Does It Differ from the Western Notary? In common-law jurisdictions (US, UK, etc.), a "notary public" is typically a low-level official who verifies identity and witnesses signatures. I...
Get link
Facebook
X
Pinterest
Email
Other Apps
Pharmacy and Drug Retail Regulation in Korea: A Legal Guide for Foreign Pharmaceutical Companies (EN/中文/日本語/Español)
Get link
Facebook
X
Pinterest
Email
Other Apps
-
🌐 Language / 語言 / 言語 / Idioma:
📋 Korean Law Insight | Pharmaceutical Regulation
By Attorney NOH UJIN | HANBYOL LAW LLC, Seoul
South Korea's pharmacy and drug retail sector is one of the most tightly regulated consumer industries in the country. For foreign pharmaceutical companies, drugstore chains, and e-commerce health platforms seeking to enter the Korean market, understanding the Pharmaceutical Affairs Act (약사법) and related regulations administered by the Ministry of Food and Drug Safety (MFDS) is essential before any investment or distribution decision is made.
1. Who May Operate a Pharmacy in Korea
Under Article 20 of the Pharmaceutical Affairs Act, only a licensed pharmacist (약사) who has passed the Korean national pharmacist licensing examination may open and operate a pharmacy. Crucially, Korean law prohibits corporate ownership of retail pharmacies — a pharmacy must be individually owned and operated by a licensed pharmacist, not by a company, franchise corporation, or foreign investment vehicle. This is a major structural difference from jurisdictions such as the United States or the United Kingdom, where pharmacy chains can be corporately owned.
As a result, foreign drugstore brands wishing to enter Korea typically do so through (a) licensing/franchising arrangements where a Korean-licensed pharmacist operates under a brand name, (b) wholesale distribution of over-the-counter (OTC) products to independently owned pharmacies, or (c) cosmetics/quasi-drug retail formats that fall outside the strict pharmacist-ownership rule.
2. Drug Classification and Distribution Channels
Korean law classifies pharmaceutical products into prescription drugs (전문의약품), over-the-counter drugs (일반의약품), and designated OTC items that may be sold in general retail stores under the "Convenience Store Medicine" system (안전상비의약품) introduced in 2012 — limited to 13 specific items such as basic pain relievers and antacids, sold only during hours when pharmacies are closed.
All imported pharmaceuticals must go through MFDS product approval, Good Manufacturing Practice (GMP) certification of the overseas manufacturing site, and registration of a Korean licensed importer. Foreign manufacturers without a Korean entity typically appoint a local distributor holding an Import Drug License to handle customs clearance, pharmacovigilance reporting, and adverse event monitoring obligations under Korean law.
3. E-Commerce and Online Sales Restrictions
Unlike many Western markets, Korea prohibits the online sale of both prescription and OTC medications through general e-commerce platforms. Online "pharmacy" platforms may only facilitate reservation of prescriptions for in-person pickup, telemedicine-linked prescription delivery under pilot programs, or sales of health functional foods (건강기능식품) and quasi-drugs, which are subject to a separate and somewhat more permissive regulatory track under the Health Functional Food Act.
4. Health Functional Foods and Cosmetics as Entry Points
Many foreign companies enter the Korean market not through pharmaceutical products but through health functional foods or cosmeceutical ("quasi-drug") products, which carry lighter regulatory burdens. Health functional foods require MFDS functional claim approval or use of pre-approved standardized ingredients, while quasi-drugs (such as medicated shampoos, hand sanitizers, and certain skin treatments) require manufacturing/import reporting but not full clinical approval.
5. Penalties for Non-Compliance
Operating a pharmacy without a license, illegal drug importation, or unauthorized online drug sales can result in criminal penalties under the Pharmaceutical Affairs Act, including imprisonment of up to 5 years or fines up to KRW 50 million, in addition to administrative sanctions such as business suspension or license revocation. Corporate entities found facilitating illegal pharmacy ownership structures (e.g., disguised franchise control over pharmacist decision-making) have faced enforcement actions from both MFDS and the Korean Pharmaceutical Association.
Frequently Asked Questions (FAQ)
Q1: Can a foreign company directly own and operate a pharmacy in Korea?
No. Only a natural person holding a Korean pharmacist license may own a retail pharmacy. Foreign companies cannot directly own pharmacy storefronts, though they may supply products, license brand names, or operate adjacent retail formats such as health food stores or cosmetic shops.
Q2: What is the difference between prescription and OTC drug import requirements?
Both require MFDS product approval and GMP certification, but prescription drugs require additional clinical data review, physician distribution controls, and stricter pharmacovigilance reporting timelines (15 days for serious adverse events vs. periodic reporting for OTC products).
Q3: How does Korea's pharmacy regulation compare to the US and EU?
Item
Korea
United States
European Union
Corporate pharmacy ownership
Prohibited
Allowed (chain pharmacies)
Varies by member state
Online OTC/Rx sales
Largely prohibited
Allowed with licensing
Allowed with licensing
Convenience store OTC items
13 designated items
Broad OTC retail
Varies
Q4: What is the process for registering an imported drug with MFDS?
The process generally involves: (1) appointing a Korean licensed importer/distributor, (2) submitting dossiers for product safety and efficacy review, (3) GMP certification of the manufacturing facility (often via on-site or documentary audit), (4) product labeling review in Korean, and (5) final import license issuance — typically taking 6-18 months depending on drug classification.
Q5: Are health functional foods a faster market entry route?
Yes. Health functional foods using MFDS pre-approved standardized ingredients can often be registered within 1-3 months, compared to the much longer clinical review process for pharmaceutical products, making this a popular initial entry strategy for foreign nutraceutical brands.
Q6: What penalties apply for illegal online drug sales?
Unauthorized online sale of medications can trigger criminal prosecution under Article 93-94 of the Pharmaceutical Affairs Act, with penalties up to 5 years imprisonment or KRW 50 million in fines, plus platform-level takedown orders from MFDS.
Q7: Does a foreign pharmaceutical company need a Korean legal representative?
Yes, foreign manufacturers typically must appoint a local responsible person (often via their Korean importer) for regulatory correspondence, adverse event reporting, and recall coordination with MFDS.
Compliance Checklist for Foreign Pharmaceutical Entrants
Determine product classification (drug, quasi-drug, health functional food, cosmetic)
Identify and contract with a licensed Korean importer/distributor
Prepare GMP certification documentation for the manufacturing site
Submit MFDS product dossier with Korean-language labeling
Establish pharmacovigilance and recall response protocols
Structure retail partnerships compliant with pharmacist-ownership rules
Need Legal Assistance?
HANBYOL LAW LLC provides expert Korean legal counsel for international clients.
📧 ujin95@hanbl.co.kr | 🌐 www.hanbl.co.kr Initial consultations are complimentary.
El sector de farmacias y venta minorista de medicamentos de Corea del Sur es una de las industrias de consumo más estrictamente reguladas del país. Para las empresas farmacéuticas extranjeras, cadenas de farmacias y plataformas de comercio electrónico de salud que buscan ingresar al mercado coreano, comprender la Ley de Asuntos Farmacéuticos (약사법) y las regulaciones relacionadas administradas por el Ministerio de Seguridad de Alimentos y Medicamentos (MFDS) es esencial antes de tomar cualquier decisión de inversión o distribución.
1. Quién Puede Operar una Farmacia en Corea
Según el Artículo 20 de la Ley de Asuntos Farmacéuticos, solo un farmacéutico con licencia (약사) que haya aprobado el examen nacional coreano de licencia farmacéutica puede abrir y operar una farmacia. La ley coreana prohíbe la propiedad corporativa de farmacias minoristas: una farmacia debe ser propiedad y estar operada individualmente por un farmacéutico con licencia, no por una empresa, corporación de franquicia o vehículo de inversión extranjera. Esta es una diferencia estructural importante respecto a jurisdicciones como Estados Unidos o el Reino Unido, donde las cadenas de farmacias pueden ser de propiedad corporativa.
Como resultado, las marcas extranjeras de farmacias que desean ingresar a Corea generalmente lo hacen a través de (a) acuerdos de licencia/franquicia donde un farmacéutico con licencia coreana opera bajo un nombre de marca, (b) distribución mayorista de productos de venta libre (OTC) a farmacias de propiedad independiente, o (c) formatos de venta minorista de cosméticos/cuasi-medicamentos que quedan fuera de la estricta regla de propiedad por farmacéuticos.
2. Clasificación de Medicamentos y Canales de Distribución
La ley coreana clasifica los productos farmacéuticos en medicamentos recetados (전문의약품), medicamentos de venta libre (일반의약품) y artículos OTC designados que pueden venderse en tiendas minoristas generales bajo el sistema de "Medicamentos de Tienda de Conveniencia" (안전상비의약품) introducido en 2012, limitado a 13 artículos específicos como analgésicos básicos y antiácidos, vendidos solo durante horas en que las farmacias están cerradas.
Todos los productos farmacéuticos importados deben pasar por la aprobación de producto del MFDS, la certificación de Buenas Prácticas de Manufactura (GMP) del sitio de fabricación en el extranjero y el registro de un importador con licencia coreana. Los fabricantes extranjeros sin una entidad coreana generalmente designan un distribuidor local que posea una Licencia de Importación de Medicamentos para manejar el despacho de aduanas, la farmacovigilancia y las obligaciones de monitoreo de eventos adversos bajo la ley coreana.
3. Restricciones de Comercio Electrónico y Ventas en Línea
A diferencia de muchos mercados occidentales, Corea prohíbe la venta en línea de medicamentos tanto recetados como de venta libre a través de plataformas de comercio electrónico generales. Las plataformas de "farmacia" en línea solo pueden facilitar la reserva de recetas para recogida en persona, la entrega de recetas vinculada a telemedicina bajo programas piloto, o la venta de alimentos funcionales para la salud (건강기능식품) y cuasi-medicamentos, que están sujetos a una vía regulatoria separada y algo más permisiva bajo la Ley de Alimentos Funcionales para la Salud.
4. Alimentos Funcionales para la Salud y Cosméticos como Puntos de Entrada
Muchas empresas extranjeras ingresan al mercado coreano no a través de productos farmacéuticos sino a través de alimentos funcionales para la salud o productos cosmecéuticos ("cuasi-medicamentos"), que tienen cargas regulatorias más ligeras. Los alimentos funcionales para la salud requieren la aprobación de declaración funcional del MFDS o el uso de ingredientes estandarizados previamente aprobados, mientras que los cuasi-medicamentos (como champús medicados, desinfectantes de manos y ciertos tratamientos para la piel) requieren notificación de fabricación/importación pero no aprobación clínica completa.
5. Sanciones por Incumplimiento
Operar una farmacia sin licencia, la importación ilegal de medicamentos o las ventas no autorizadas de medicamentos en línea pueden resultar en sanciones penales bajo la Ley de Asuntos Farmacéuticos, incluyendo prisión de hasta 5 años o multas de hasta 50 millones de KRW, además de sanciones administrativas como suspensión de negocios o revocación de licencia.
Preguntas Frecuentes (FAQ)
P1: ¿Puede una empresa extranjera poseer y operar directamente una farmacia en Corea?
No. Solo una persona física con licencia de farmacéutico coreano puede poseer una farmacia minorista. Las empresas extranjeras no pueden poseer directamente tiendas de farmacia, aunque pueden suministrar productos, licenciar nombres de marca u operar formatos minoristas adyacentes.
P2: ¿Cuál es la diferencia entre los requisitos de importación de medicamentos recetados y de venta libre?
Ambos requieren aprobación de producto del MFDS y certificación GMP, pero los medicamentos recetados requieren revisión de datos clínicos adicionales, controles de distribución por médicos y plazos de informes de farmacovigilancia más estrictos.
P3: ¿Cómo se compara la regulación farmacéutica de Corea con EE. UU. y la UE?
Elemento
Corea
Estados Unidos
Unión Europea
Propiedad corporativa de farmacias
Prohibida
Permitida (cadenas)
Varía por estado miembro
Ventas en línea OTC/Rx
Mayormente prohibida
Permitida con licencia
Permitida con licencia
Artículos OTC en tiendas de conveniencia
13 artículos designados
Venta minorista OTC amplia
Varía
P4: ¿Cuál es el proceso para registrar un medicamento importado con el MFDS?
El proceso generalmente implica: (1) designar un importador/distribuidor con licencia coreana, (2) presentar expedientes para revisión de seguridad y eficacia, (3) certificación GMP de la instalación de fabricación, (4) revisión del etiquetado del producto en coreano, y (5) emisión final de la licencia de importación, generalmente tomando de 6 a 18 meses.
P5: ¿Son los alimentos funcionales para la salud una vía de entrada al mercado más rápida?
Sí. Los alimentos funcionales para la salud que utilizan ingredientes estandarizados preaprobados por el MFDS a menudo pueden registrarse en 1 a 3 meses, en comparación con el proceso de revisión clínica mucho más largo para productos farmacéuticos.
P6: ¿Qué sanciones se aplican por ventas ilegales de medicamentos en línea?
La venta en línea no autorizada de medicamentos puede desencadenar un proceso penal bajo los Artículos 93-94 de la Ley de Asuntos Farmacéuticos, con penas de hasta 5 años de prisión o 50 millones de KRW en multas.
P7: ¿Necesita una empresa farmacéutica extranjera un representante legal coreano?
Sí, los fabricantes extranjeros generalmente deben designar un responsable local (a menudo a través de su importador coreano) para correspondencia regulatoria, informes de eventos adversos y coordinación de retiro de productos.
🌐 Language / 語言 / 言語 / Idioma: English 中文 日本語 Español 📋 Korean Law Insight | Transportation Law By Attorney NOH UJIN | HANBYOL LAW LLC, Seoul Korea's passenger transport sector — taxis, car-sharing platforms, and ride-hailing-adjacent services — operates under one of the most tightly regulated mobility frameworks in Asia. Foreign mobility companies, investors, and platform operators considering entry into the Korean market must navigate the Passenger Transport Service Act (여객자동차 운수사업법), licensing quotas, and a legal environment shaped by years of conflict between incumbent taxi operators and new mobility platforms. This guide explains the legal landscape for taxi and car-sharing regulation in Korea. 1. The Passenger Transport Service Act: Licensing Structure All passenger transport businesses in Korea — including taxis, limousine services, and chartered vehicles — require a license under the Passenger Transport Service Act, issued by munici...
How Foreign Creditors Can Recover Debts in South Korea: A Step-by-Step Legal Guide How Foreign Creditors Can Recover Debts in South Korea: A Step-by-Step Legal Guide By Attorney NOH UJIN | HANBYOL LAW LLC, Seoul Labels: Debt Recovery • Cross-Border Litigation • Korean Legal System EN 中文 日本語 Español South Korea's sophisticated legal infrastructure makes it one of the more creditor-friendly jurisdictions in Asia — if you know how to navigate it. For foreign businesses owed money by Korean debtors, understanding the step-by-step legal process is essential to protecting your financial interests. This guide walks you through the primary pathways available under Korean law. 1. Understanding Your Legal Foundations Debt recovery in Korea is governed primarily by two statutes: the Civil Procedure Act (민사소송법) for initiating and conducting litigation, and the Civil E...
Commercial Arbitration in South Korea: What Foreign Businesses Must Know Commercial Arbitration in South Korea: What Foreign Businesses Must Know By Attorney NOH UJIN | HANBYOL LAW LLC, Seoul Labels: Cross-Border Litigation • Business Law • Korean Legal System EN 中文 日本語 Español South Korea has firmly positioned itself as a leading arbitration hub in Northeast Asia. Seoul is home to the Korean Commercial Arbitration Board (대한상사중재원, KCAB), one of the most active arbitral institutions in the region. For foreign businesses entering contracts with Korean counterparties — or seeking to enforce arbitral awards against them — a working knowledge of Korea's arbitration framework is indispensable. 1. The Legal Framework: The Korean Arbitration Act The primary statute governing arbitration in Korea is the Arbitration Act (중재법). Korea substantially reformed its Arbitr...
Comments
Post a Comment